Work

Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.1029

Authors: Heidi Chwan Ko, Sarabjot Pabla, Mary K Nesline, Kyle C Strickland, Rebecca A. Previs, Zachary D Wallen, Shengle Zhang, Jeffrey M. Conroy, Mark Sausen, Jennifer B Jackson, Kamal S. Saini, Scott Wise, Taylor J. Jensen, Venkataprasanth P. Reddy, Eric A Severson, Shakti Ramkissoon

Institutions: LabCorp (United States), Duke Medical Center, Duke Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379328966

Cites:

Cited by: 1

Related to: 10